SMTL ID : 4g9c.1 (1 other biounit)

Human B-Raf Kinase Domain bound to a Type II Pyrazolopyridine Inhibitor

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 3.50 Å

Oligo State

monomer

Ligands

1 x 0WP: 3-{[3-(2-cyanopropan-2-yl)benzoyl]amino}-2,6-difluoro-N-(3-methoxy-2H-pyrazolo[3,4-b]pyridin-5-yl)benzamide(Non-covalent)

0WP.1: 23 residues within 4Å: Chain A: I.44, V.52, A.62, V.63, K.64, E.82, V.85, L.86, I.94, L.95, I.108, T.110, Q.111, W.112, C.113, I.153, H.155, F.164, G.174, D.175, F.176, A.179, T.180 15 PLIP interactions: 15 interactions with chain A Hydrophobic interactions: A:K.64, A:E.82, A:L.86, A:I.94, A:I.108, A:T.110, A:D.175 Hydrogen bonds: A:E.82, A:E.82, A:T.110, A:T.110, A:C.113, A:D.175 pi-Stacking: A:W.112, A:F.176

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Wenglowsky, S. et al., Pyrazolopyridine inhibitors of B-Raf(V600E). Part 4: Rational design and kinase selectivity profile of cell potent type II inhibitors. Bioorg.Med.Chem.Lett. (2012)

Release Date

2012-11-14

Peptides

Serine/threonine-protein kinase B-raf: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Serine/threonine-protein kinase B-raf

Related Entries With Identical Sequence